drugset / Trial / NCT00856687
A Study To Assess The Effect Of PF-03893787 On Lung Function Following An Allergen Challenge In Asthmatic Subjects
RandomizedCrossoverDouble-blindTreatment
Summary
PF-03893787, a novel anti-inflammatory agent should attenuate the effect of a bronchial allergen challenge on lung function and hence provide proof of mechanism for this agent.
Timeline
- Start
- 2009-04
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ADRIFORANT | Small molecule | — | Oral |
| Comparator | Montelukast | Other / unclassified | — | Oral |